Combination of a Novel Growth Hormone Releasing Hormone Antagonist JMR 132 and Tamoxifen Enhances the Inhibitory Effects on Growth of ZR 75 and T47D Estrogen Dependent Human Breast Cancer Cells In Vitro and In Vivo

Buchholz, S. and Koester, F. and Schally, A. and Krishan, A. and Papadia, A. and Ortmann, O. and Seitz, S. (2009) Combination of a Novel Growth Hormone Releasing Hormone Antagonist JMR 132 and Tamoxifen Enhances the Inhibitory Effects on Growth of ZR 75 and T47D Estrogen Dependent Human Breast Cancer Cells In Vitro and In Vivo. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 27 Apr 2021 05:04
Last Modified: 27 Apr 2021 05:04
URI: https://pred.uni-regensburg.de/id/eprint/27974

Actions (login required)

View Item View Item